NewKerala.com

India's Bioeconomy Soars to $195 Billion, Eyes $300 Billion by 2030

India's bioeconomy has expanded dramatically to over $195 billion in 2025, a near 20-fold increase from approximately $10 billion in 2014. The sector is growing at an annual rate of 17-18% and now contributes about 4.8% to the nation's GDP. Key drivers include over 11,800 biotech startups and supportive government policies like the BioE3 Policy and a Rs 1 lakh crore RDI Fund. Union Minister Dr Jitendra Singh stated the country is on track to achieve its $300 billion bioeconomy target by 2030.

Key Points: India's Bioeconomy Hits $195B, Growing at 17-18% Annually

  • Sector grew from $10B in 2014 to $195B in 2025
  • Annual growth rate of 17-18%
  • Over 11,800 biotech startups in India
  • Contributes 4.8% to India's GDP
  • Supported by new BioE3 Policy and RDI Fund
2 min read

India's bioeconomy increases nearly 20-fold to $195 billion: Dr Jitendra Singh

India's bioeconomy surged from $10B to $195B, now 4.8% of GDP, with over 11,800 startups driving innovation in biotech.

"India is steadily moving towards its target of a $300 billion bioeconomy by 2030. - Dr Jitendra Singh"

New Delhi, March 19

Union Minister Dr Jitendra Singh on Thursday said that India's bioeconomy has expanded significantly to over $195 billion in 2025, from around $10 billion in 2014.

Addressing the 14th Foundation Day of the Biotechnology Industry Research Assistance Council (BIRAC) here, the minister said the sector has witnessed strong growth, registering an annual expansion of around 17-18 per cent in the past year alone.

He noted that biotechnology is emerging as a key pillar of India's growth story, contributing to advancements in healthcare, agriculture, climate solutions, and sustainable manufacturing.

Dr Singh said India is steadily moving towards its target of a $300 billion bioeconomy by 2030, supported by a growing base of scientists, startups and entrepreneurs.

Highlighting the role of BIRAC, he said the organisation has been instrumental in bridging the gap between research and industry, helping translate innovations into market-ready solutions.

Referring to policy initiatives, the minister spoke about the BioE3 Policy aimed at strengthening bio-based industries and promoting sustainable biomanufacturing. He said the policy will support innovation in areas such as biotherapeutics, climate-resilient agriculture and bio-based chemicals.

Dr Singh also highlighted the government's Research, Development and Innovation (RDI) Fund with an outlay of Rs 1 lakh crore, under which the BIRAC will play a key role in supporting biotechnology ventures and scaling up innovations.

During the event, the India Bioeconomy Report 2026 and the BIRAC Impact Report were released, which showed that the sector has more than doubled since 2020 and now contributes around 4.8 per cent to the country's GDP.

The report also highlighted that India has over 11,800 biotech startups, reflecting the rapid growth of the innovation ecosystem, the government said.

The minister also emphasised the need to nurture young talent, particularly from smaller cities, and called for greater collaboration between industry, academia and policymakers to drive innovation and economic growth.

- IANS

Share this article:

Reader Comments

P
Priya S
Great to see biotech contributing to climate solutions and agriculture. As a farmer's daughter, I hope innovations in climate-resilient crops reach the grassroots level quickly and are affordable. That's the real test of success.
S
Sarah B
Impressive numbers. The 17-18% annual growth rate is world-class. If this momentum continues, the $300B target by 2030 seems very achievable. The key will be sustaining the startup ecosystem and preventing brain drain.
V
Vikram M
While the growth is commendable, I hope the benefits are distributed evenly. The minister's call to nurture talent from smaller cities is crucial. Development shouldn't just be about Bangalore and Hyderabad. We need hubs in Tier 2 & 3 cities as well.
R
Rohit P
The Rs 1 lakh crore RDI Fund is a massive commitment. Hope it's implemented transparently and reaches the actual innovators, not just the established players. BIRAC has a big responsibility to bridge that research-industry gap effectively.
M
Michael C
4.8% of GDP from bioeconomy is a significant contribution. This sector could be a major driver for 'Make in India' in pharmaceuticals and medical devices. Hoping for more affordable healthcare solutions from these innovations.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50